Genpathway

Invivoscribe Technologies, located in San Diego, CA, specializes in personalized molecular medicine, offering internationally standardized testing for crucial biomarkers that enhance patient care. Their extensive service portfolio includes next-generation sequencing, companion diagnostics, and various hematological testing options, aimed at improving treatment outcomes for cancers such as lymphoma and multiple myeloma. The company is dedicated to advancing science in personalized medicine, leveraging genomic and patient-specific data to tailor optimal treatment plans. With a commitment to quality healthcare and global regulatory expertise, Invivoscribe fosters partnerships to facilitate drug approvals and the development of innovative diagnostic assays. Generated from the website